Trial
NCT04616079
Ascending Dose Study of the Safety and Tolerability of REGN6490 in Healthy Volunteers
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Regeneron Pharmaceuticals
Collaborators
—
Condition
Healthy Volunteer
Intervention
REGN6490
Why stopped
Sponsor decision
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-11-11